Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-30T06:13:52.104Z Has data issue: false hasContentIssue false
  • English
  • Français

Anxiety and Depression among Patients Admitted at COVID wards of East Avenue Medical Center (EAMC) Using the Validated Filipino Version of the Hospital Anxiety and Depression Scale (HADS-P)

Published online by Cambridge University Press:  01 September 2022

F.J. Guiang  and
M.A. Gabaon
F.J. Guiang*
Affiliation:
East Avenue Medical Center, Internal Medicine, Quezon City, Philippines
M.A. Gabaon
Affiliation:
East Avenue Medical Center, Internal Medicine, Quezon City, Philippines
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

COVID-19 is a multifaceted disease establishing differences in terms of its occurrence, manner of clinical presentation and disease predilection. While mental health becomes one of the less analyzed aspects, addressing anxiety and depression allows clinicians to provide more patient-centered care in this pandemic era.

Objectives

This study determined the prevalence of anxiety and depressive symptoms among patients admitted for at least 14 days at COVID wards of East Avenue Medical using the validated Filipino version of the Hospital Anxiety and Depression Scale (HADS-P), and described the socioeconomic, psychosocial, clinical factors affecting its development among COVID-19 patients.

Methods

232 patients admitted at COVID ward of East Avenue Medical Center for at least 14 days were included in the study. Participants were interviewed using the validated Filipino version of the Hospital Anxiety and Depression Score (HADS-P) questionnaire. STATA 13.1 was used for data analysis at 95% confidence interval

Results

Anxiety was significantly correlated with hypertension (p= 0.044), diabetes (p= 0.008), employment status (p= 0.038), and with patients who had family members with COVID- 19 (p= 0.033). Depressive symptoms occurred more likely in Chronic Kidney Disease and in COVID-19 suspects. Most participants had a normal HADS-P anxiety (6) and depression (4) median scores. Mild symptoms of anxiety (n=55) and depression (n=30) were noted among participants. The severity of COVID-19 classification was a statistically significant variable for developing anxiety symptoms.

Conclusions

Identifying predictors of developing anxiety and depressive symptoms enables us to develop better strategies in addressing mental health as one of the important aspects of patient management during this pandemic.

Disclosure

No significant relationships.

Keywords

DepressionAnxietyHADSCovid-19
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S534 - S535
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.